Antibody Signature of Spontaneous Clearance of Chlamydia trachomatis Ocular Infection and Partial Resistance against Re-challenge in a Nonhuman Primate Trachoma Model

PLoS Neglected Tropical Diseases

Volumn 7, Issue 5, 2013, Pages

  Kari, Laszlo ^a   Bakios, Lauren E ^a   Goheen, Morgan M ^a   Bess, Leah N ^a   Watkins, Heather S ^a   Southern, Timothy R ^a   Song, Lihua ^a   Whitmire, William M ^a   Olivares Zavaleta, Norma ^a   Caldwell, Harlan D ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OUTER MEMBRANE PROTEIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ANTIGENIC VARIATION; ARTICLE; BACTERIAL CLEARANCE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; EYE INFECTION; GENE SEQUENCE; HEAT SENSITIVITY; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; MACACA FASCICULARIS; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; RADIOIMMUNOPRECIPITATION; TRACHOMA; WESTERN BLOTTING;

EID: 84878484498     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002248     Document Type: Article

References (28)

1. Yuan Y, Zhang Y-X, Watkins NG, Caldwell HD, (1989) Nucleotide and deduced amino acid sequences for the four variable domains of the major outer membrane proteins of the 15 Chlamydia trachomatis serovars. Infect Immun 57: 1040-1049.
2. Schachter J, (1978) Chlamydial infections (Third of three parts). N Engl J Med 298: 540-549.
3. WHO (2010) Working to overcome the global impact of neglected tropical diseases. Geneva, Switzerland.
4. Burton MJ, Mabey DC, (2009) The global burden of trachoma: a review. PLoS Negl Trop Dis 3: e460.
5. Kari L, Whitmire WM, Crane DD, Reveneau N, Carlson JH, et al. (2009) Chlamydia trachomatis native major outer membrane protein induces partial protection in nonhuman primates: implication for a trachoma transmission-blocking vaccine. J Immunol 182: 8063-8070.
6. Caldwell HD, Kromhout J, Schachter J, (1981) Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun 31: 1161-1176.
7. Kari L, Whitmire WM, Carlson JH, Crane DD, Reveneau N, et al. (2008) Pathogenic diversity among Chlamydia trachomatis ocular strains in non-human primates is affected by subtle genomic variations. J Infect Dis 197: 449-456.
8. Matsumoto A, Izutsu H, Miyashita N, Ohuchi M, (1998) Plaque formation by and plaque cloning of Chlamydia trachomatis biovar trachoma. J Clin Microbiol 36: 3013-3019.
9. Carlson JH, Porcella SF, McClarty G, Caldwell HD, (2005) Comparative genomic analysis of Chlamydia trachomatis oculotropic and genitotropic strains. Infect Immun 73: 6407-6418.
10. Swanson KA, Taylor LD, Frank SD, Sturdevant GL, Fischer ER, et al. (2009) Chlamydia trachomatis polymorphic membrane protein D is an oligomeric autotransporter with a higher-order structure. Infect Immun 77: 508-516.
11. Zhong G, Fan P, Ji H, Dong F, Huang Y, (2001) Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J Exp Med 193: 935-942.
12. Comanducci M, Manetti R, Bini L, Santucci A, Pallini V, et al. (1994) Humoral immune response to plasmid protein pgp3 in patients with Chlamydia trachomatis infection. Infect Immun 62: 5491-5497.
13. Murthy AK, Cong Y, Murphey C, Guentzel MN, Forsthuber TG, et al. (2006) Chlamydial protease-like activity factor induces protective immunity against genital chlamydial infection in transgenic mice that express the human HLA-DR4 allele. Infect Immun 74: 6722-6729.
14. Li Z, Chen C, Chen D, Wu Y, Zhong Y, et al. (2008) Characterization of fifty putative inclusion membrane proteins encoded in the Chlamydia trachomatis genome. Infect Immun 76: 2746-2757.
15. Li Z, Chen D, Zhong Y, Wang S, Zhong G, (2008) The chlamydial plasmid-encoded protein pgp3 is secreted into the cytosol of Chlamydia-infected cells. Infect Immun 76: 3415-3428.
16. Chen D, Lei L, Lu C, Galaleldeen A, Hart PJ, et al. (2010) Characterization of Pgp3, a Chlamydia trachomatis plasmid-encoded immunodominant antigen. J Bacteriol 192: 6017-6024.
17. Andreasen AA, Burton MJ, Holland MJ, Polley S, Faal N, et al. (2008) Chlamydia trachomatis ompA variants in trachoma: what do they tell us? PLoS Negl Trop Dis 2: e306.
18. Hsieh YH, Bobo LD, Quinn TC, West SK, (2001) Determinants of trachoma endemicity using Chlamydia trachomatis ompA DNA sequencing. Microbes Infect 3: 447-458.
19. Caldwell HD, Stewart S, Johnson S, Taylor H, (1987) Tear and serum antibody response to Chlamydia trachomatis antigens during acute chlamydial conjunctivitis in monkeys as determined by immunoblotting. Infect Immun 55: 93-98.
20. Pal S, Peterson EM, de la Maza LM, (2005) Vaccination with the Chlamydia trachomatis Major Outer Membrane Protein Can Elicit an Immune Reponse as Protective as That Resulting from Inoculation with Live Bacteria. Infect Immun 73: 8153-8160.
21. Lu C, Holland MJ, Gong S, Peng B, Bailey RL, et al. (2012) Genome-wide identification of Chlamydia trachomatis antigens associated with trachomatous trichiasis. Invest Ophthalmol Vis Sci 53: 2551-2559.
22. Chaganty BK, Murthy AK, Evani SJ, Li W, Guentzel MN, et al. (2010) Heat denatured enzymatically inactive recombinant chlamydial protease-like activity factor induces robust protective immunity against genital chlamydial challenge. Vaccine 28: 2323-2329.
23. Cong Y, Jupelli M, Guentzel MN, Zhong G, Murthy AK, et al. (2007) Intranasal immunization with chlamydial protease-like activity factor and CpG deoxynucleotides enhances protective immunity against genital Chlamydia muridarum infection. Vaccine 25: 3773-3780.
24. Li W, Guentzel MN, Seshu J, Zhong G, Murthy AK, et al. (2007) Induction of cross-serovar protection against genital chlamydial infection by a targeted multisubunit vaccination approach. Clin Vaccine Immunol 14: 1537-1544.
25. Murphey C, Murthy AK, Meier PA, Neal Guentzel M, Zhong G, et al. (2006) The protective efficacy of chlamydial protease-like activity factor vaccination is dependent upon CD4+ T cells. Cell Immunol 242: 110-117.
26. Murthy AK, Chambers JP, Meier PA, Zhong G, Arulanandam BP, (2007) Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production. Infect Immun 75: 666-676.
27. Li Z, Wang S, Wu Y, Zhong G, Chen D, (2008) Immunization with chlamydial plasmid protein pORF5 DNA vaccine induces protective immunity against genital chlamydial infection in mice. Sci China C Life Sci 51: 973-980.
28. Kari L, Whitmire WM, Olivares-Zavaleta N, Goheen MM, Taylor LD, et al. (2011) A live-attenuated chlamydial vaccine protects against trachoma in nonhuman primates. J Exp Med 208: 2217-2223.